The study included 17,604 adults over the age of 45 from across 41 countries, each with a BMI of more than 27 and established cardiovascular disease, with no history of diabetes
In addition to weight reduction, GLP-1 agonists improve glycemic control in people with type 2 diabetes, making them a powerful tool for managing both weight and metabolic health
Scioli, on emerging research showing reduced heavy drinking days among study participants with alcohol use disorder and obesity
But Kind Patches is not a GLP-1 clinic, and its patches do not contain any GLP-1 drugs
However, treatment decisions should always be individualized, taking into account a patient's medical history, risk factors, treatment goals, and guidance from healthcare professionals
Fraser A, Tilling K, Macdonald-Wallis C, Sattar N, Brion MJ, Benfield L, et al